237 related articles for article (PubMed ID: 32295420)
1. Cardiovascular Biology of Prostanoids and Drug Discovery.
Zhu L; Zhang Y; Guo Z; Wang M
Arterioscler Thromb Vasc Biol; 2020 Jun; 40(6):1454-1463. PubMed ID: 32295420
[TBL] [Abstract][Full Text] [Related]
2. Prostanoids in Cardiac and Vascular Remodeling.
Ricciotti E; Haines PG; Chai W; FitzGerald GA
Arterioscler Thromb Vasc Biol; 2024 Mar; 44(3):558-583. PubMed ID: 38269585
[TBL] [Abstract][Full Text] [Related]
3. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory drugs in the 21st century.
Rainsford KD
Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
[TBL] [Abstract][Full Text] [Related]
5. An Update of Microsomal Prostaglandin E Synthase-1 and PGE2 Receptors in Cardiovascular Health and Diseases.
Yang G; Chen L
Oxid Med Cell Longev; 2016; 2016():5249086. PubMed ID: 27594972
[TBL] [Abstract][Full Text] [Related]
6. A profile of NSAID-targeted arachidonic acid metabolisms in human embryonic stem cells (hESCs): implication of the negative effects of NSAIDs on heart tissue regeneration.
Chillar A; So SP; Ruan CH; Shelat H; Geng YJ; Ruan KH
Int J Cardiol; 2011 Aug; 150(3):253-9. PubMed ID: 20451268
[TBL] [Abstract][Full Text] [Related]
7. Adverse effects of COX-2 inhibitors.
Sharma JN; Jawad NM
ScientificWorldJournal; 2005 Aug; 5():629-45. PubMed ID: 16113940
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review.
Koeberle A; Werz O
Curr Med Chem; 2009; 16(32):4274-96. PubMed ID: 19754418
[TBL] [Abstract][Full Text] [Related]
9. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
Galli G; Panzetta G
G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
[TBL] [Abstract][Full Text] [Related]
10. PGE synthase inhibitors as an alternative to COX-2 inhibitors.
Jachak SM
Curr Opin Investig Drugs; 2007 May; 8(5):411-5. PubMed ID: 17520870
[TBL] [Abstract][Full Text] [Related]
11. Druggable Prostanoid Pathway.
Mazaleuskaya LL; Ricciotti E
Adv Exp Med Biol; 2020; 1274():29-54. PubMed ID: 32894506
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 inhibitors: a painful lesson.
Sanghi S; MacLaughlin EJ; Jewell CW; Chaffer S; Naus PJ; Watson LE; Dostal DE
Cardiovasc Hematol Disord Drug Targets; 2006 Jun; 6(2):85-100. PubMed ID: 16787194
[TBL] [Abstract][Full Text] [Related]
13. The anti-inflammatory and vasoprotective properties of mPGES-1 inhibition offer promising therapeutic potential.
Steinmetz-Späh J; Jakobsson PJ
Expert Opin Ther Targets; 2023; 27(11):1115-1123. PubMed ID: 38015194
[TBL] [Abstract][Full Text] [Related]
14. [Research advances of prostaglandin E
Liu M; Guo MN; Chen LH
Sheng Li Xue Bao; 2021 Aug; 73(4):665-680. PubMed ID: 34405222
[TBL] [Abstract][Full Text] [Related]
15. NSAIDs and cardiovascular disease: transducing human pharmacology results into clinical read-outs in the general population.
Capone ML; Tacconelli S; Rodriguez LG; Patrignani P
Pharmacol Rep; 2010; 62(3):530-5. PubMed ID: 20631418
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase inhibitors: instrumental drugs to understand cardiovascular homeostasis and arterial thrombosis.
Bunimov N; Laneuville O
Cardiovasc Hematol Disord Drug Targets; 2008 Dec; 8(4):268-77. PubMed ID: 19075637
[TBL] [Abstract][Full Text] [Related]
17. Use of nonsteroidal anti-inflammatory drugs in patients with cardiovascular disease: a cautionary tale.
Amer M; Bead VR; Bathon J; Blumenthal RS; Edwards DN
Cardiol Rev; 2010; 18(4):204-12. PubMed ID: 20539104
[TBL] [Abstract][Full Text] [Related]
18. Microsomal prostaglandin E2 synthase: a safer target than cyclooxygenases?
Timmers L; Pasterkamp G; de Kleijn DP
Mol Interv; 2007 Aug; 7(4):195-9, 180. PubMed ID: 17827439
[TBL] [Abstract][Full Text] [Related]
19. Current perspective on the cardiovascular effects of coxibs.
Konstam MA; Weir MR
Cleve Clin J Med; 2002; 69 Suppl 1():SI47-52. PubMed ID: 12086293
[TBL] [Abstract][Full Text] [Related]
20. Prostanoids and inflammatory pain.
Chen L; Yang G; Grosser T
Prostaglandins Other Lipid Mediat; 2013; 104-105():58-66. PubMed ID: 22981510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
